Search research articles
Contact Us
Filters
Showing results (381-390 of 489) with videos related to
Page
of 49
Sort By:
Alzheimer'S Research & Therapy
|
July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutations
Simon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Plos One
|
January 26, 2011
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease
Richard J Perrin, Rebecca Craig-Schapiro, James P Malone, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Elife
|
January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
Peter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Patient Preference and Adherence
|
August 6, 2015
Perspectives of patients on factors relating to adherence to post-acute coronary syndrome medical regimens
Anne Lambert-Kerzner, Edward P Havranek, Mary E Plomondon, et al.
Biological Psychiatry
|
November 2, 2010
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease
Rebecca Craig-Schapiro, Richard J Perrin, Catherine M Roe, et al.
Neurology. Genetics
|
April 22, 2021
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
Suzanne E Schindler, Carlos Cruchaga, Amulya Joseph, et al.
Science Translational Medicine
|
November 16, 2022
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
Aylin Dincer, Charles D Chen, Nicole S McKay, et al.
Plos Genetics
|
October 24, 2014
Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation
John S K Kauwe, Matthew H Bailey, Perry G Ridge, et al.
JAMA Neurology
|
July 7, 2015
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
Courtney L Sutphen, Mateusz S Jasielec, Aarti R Shah, et al.
Page
of 49
Search research articles
Search
Showing results (381-390 of 489) with videos related to
Sort By:
Page
of 49
Alzheimer'S Research & Therapy
|
July 20, 2018
Discovery and validation of autosomal dominant Alzheimer's disease mutations
Simon Hsu, Brian A Gordon, Russ Hornbeck, et al.
Plos One
|
January 26, 2011
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease
Richard J Perrin, Rebecca Craig-Schapiro, James P Malone, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.
Elife
|
January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
Peter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Patient Preference and Adherence
|
August 6, 2015
Perspectives of patients on factors relating to adherence to post-acute coronary syndrome medical regimens
Anne Lambert-Kerzner, Edward P Havranek, Mary E Plomondon, et al.
Biological Psychiatry
|
November 2, 2010
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease
Rebecca Craig-Schapiro, Richard J Perrin, Catherine M Roe, et al.
Neurology. Genetics
|
April 22, 2021
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
Suzanne E Schindler, Carlos Cruchaga, Amulya Joseph, et al.
Science Translational Medicine
|
November 16, 2022
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
Aylin Dincer, Charles D Chen, Nicole S McKay, et al.
Plos Genetics
|
October 24, 2014
Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation
John S K Kauwe, Matthew H Bailey, Perry G Ridge, et al.
JAMA Neurology
|
July 7, 2015
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
Courtney L Sutphen, Mateusz S Jasielec, Aarti R Shah, et al.
Page
of 49